Saturday, January 19, 2008

FDA clears new Johnson & Johnson HIV drug (Reuters)



Reuters - Health-care products maker Johnson &
Johnson won U.S. approval to sell a new HIV drug called
Intelence for patients with resistance to other therapies, U.S.
officials said on Friday.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)